Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 13 | 18 | +5 |
| Shares | 1.08M | 1.99M | +914.5K (+84.9%) |
| Value | $7.87M | $7.33M | −$541.9K (−6.9%) |
New holders (8)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,068,444 | $3.93M | 0.10% |
| Millennium Management LLC | 74,559 | $274.0K | 0.00% |
| Geode Capital Management, LLC | 35,899 | $132.0K | 0.00% |
| State Street Corp | 26,447 | $97.0K | 0.00% |
| Northern Trust Corp | 16,572 | $61.0K | 0.00% |
| Wealth Architects, LLC | 14,077 | $52.0K | 0.01% |
| FMR LLC | 600 | $2.00K | 0.00% |
| TCI Wealth Advisors, Inc. | 100 | $0 | 0.00% |
Sold out (3)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Worth Venture Partners, LLC | 105,413 | $780.0K |
| UBS Group AG | 3,229 | $24.0K |
| Newbridge Financial Services Group, Inc. | 400 | $3.00K |